TheraRadar
Clinical-Stage Companies / Shanghai Fudan-Zhangjiang Bio-Pharmaceutical

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical

Pre-Approval PRO BETA
25
Total Trials
3
Phase 3
7
Phase 2
7
Recruiting
145
Score

Pipeline by Phase

Phase 3
3
Phase 2
7
Phase 1
13

Therapeutic Focus

Port-Wine Stain Papillomavirus Infections Port-wine Stain Acne Vulgaris Cervical Intraepithelial Neoplasia

Clinical Trials (25)

NCT06417281 Phase 3 COMPLETED

Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid(5-ALA)

Started: 6/19/2024

NCT06519370 Phase 3 ACTIVE NOT RECRUITING

FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer

Started: 8/9/2024

NCT06715319 Phase 3 COMPLETED

Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis

Started: 10/9/2021

NCT05171894 Phase 2 RECRUITING

A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT

Started: 9/21/2024

NCT06413615 Phase 2 RECRUITING

A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors

Started: 5/13/2024

NCT06439433 Phase 2 COMPLETED

ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection

Started: 5/31/2021

NCT02955771 Phase 2 TERMINATED

Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma

Started: 5/17/2017

NCT02631863 Phase 2 COMPLETED

Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)

Started: 3/22/2016

NCT02304770 Phase 2 COMPLETED

Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia

Started: 1/1/2015

NCT06424665 Phase 1 RECRUITING

A Study of FZ-AD005 in Patients With Advanced Solid Tumors

Started: 7/3/2024

NCT05914545 Phase 1 RECRUITING

A Study of FZ-AD004 in Patients With Advanced Solid Tumors

Started: 6/12/2023

NCT05564858 Phase 1 RECRUITING

A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors

Started: 1/16/2023

NCT07455045 Phase 1 NOT YET RECRUITING

A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

Started: 3/1/2026

NCT05174637 Phase 1 ACTIVE NOT RECRUITING

A Study of FDA018-ADC in Patients With Advanced Solid Tumors

Started: 10/22/2021

NCT04715529 Phase 1 COMPLETED

Phase 1 Study to Evaluate Safety and Pharmacokinetics of FZJ-003 in Healthy Volunteers

Started: 1/27/2021

NCT03894150 Phase 1 COMPLETED

A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies.

Started: 4/11/2019

NCT04044898 Phase 1 COMPLETED

Pharmacokinetics and Safety of ALA in Acne Vulgaris

Started: 1/12/2021

NCT04018885 Phase 1 COMPLETED

A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris

Started: 7/11/2019

NCT02291471 Phase 1 COMPLETED

Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers

Started: 10/1/2014

NCT02481180 Phase 1 TERMINATED

Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)

Started: 7/31/2015

NCT02237690 Phase 1 COMPLETED

Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer

Started: 9/1/2014

NCT01481597 Phase 1 COMPLETED

Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers

Started: 11/1/2011

NCT04106258 Phase 4 COMPLETED

A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain

Started: 5/27/2020

NCT03181984 Phase 4 COMPLETED

Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain

Started: 8/31/2017

NCT03125057 Phase 4 COMPLETED

A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain

Started: 8/2/2017

Drug Candidates

FZ-AD005 5 Aminolevulinic Acid Hemopfin+Green Light FDA018-ADC Eribulin Capecitabine Gemcitabine Vinorelbine FZ-AD004 FZJ-003
Activity Status: Active
Last Trial Started: 3/1/2026
Last Trial Ended: 8/19/2025
Trials (12 months): 1
Completed Trials: 15
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.